Trial intelligence / Profile preview

MICROS: Rosuvastatin in STEMI

NCT01382472Phase 4Completed

Sponsor
Stavanger University Hospital
Start
Sep 2011
Primary completion
Dec 2016
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of rosuvastatin in ST elevation myocardial infarction (STEMI), sponsored by Stavanger University Hospital. Started Sep 2011; status: completed.

02

Drugs

rosuvastatin
03

Conditions

ST elevation myocardial infarction (STEMI)

Beyond the preview

Go deeper on NCT01382472.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01382472.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call